102
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Desmopressin is a safe drug for the treatment of enuresis

, , , , &
Pages 308-312 | Received 12 Dec 2003, Published online: 09 Jul 2009
 

Abstract

Objective To verify the safety of desmopressin treatment and its associated side-effects in a large number of patients.Material and Methods The study was conducted in accordance with the guidelines of the Italian Club for Nocturnal Enuresis, whose criteria are: age >5 years; absence of malformations and infections of the urinary tract; absence of psychological disorders or neurological alterations; number of “wet nights” >5–7; control of liquid intake during the afternoon and evening; monitoring of serum electrolytes before beginning treatment; control of body weight before the beginning of treatment and during the first 4–5 days of therapy; and the informed consent of the parents. The therapeutic regimen provided for a maximum dose of desmopressin of 40 µg/day (four puffs/nostril or two tablets), starting from an initial dosage of 20 µg/day (two puffs/nostril or one tablet) 1 h before going to bed. The study involved two groups of patients with monosymptomatic enuresis: some of them had been administered desmopressin in the form of a spray and others in the form of tablets.Results A small percentage of patients presented mild, transient side-effects; in no case were severe side-effects verified.Conclusion Desmopressin is a safe drug with a low incidence of side-effects.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 65.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.